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Abstract
Background: Dyslipidemia is a risk factor for incident type 2 diabetes; however, no study has specifically assessed
the lipid ratios (i.e. total cholesterol (TC)/high density lipoprotein cholesterol (HDL-C) and triglyceride (TG)/HDL-C)
as predictors of diabetes. We aimed to compare the independent association between the different lipid measures
with incident diabetes over a median follow up of 6.4 years in Iranian men and women.
Method: The study population consisted of 5201 non diabetic (men = 2173, women = 3028) subjects, aged ≥20
years. The risk factor adjusted odds ratios (ORs) for diabetes were calculated for every 1 standard deviation (SD)
change in TC, log-transformed TG, HDL-C, non-HDL-C, TC/HDL-C and log-transformed TG/HDL-C using multivariate
logistic regression analysis. Receiver operator characteristic (ROC) curve analysis was used to define the points of
the maximum sum of sensitivity and specificity (MAXss) of each lipid measure as a predictor of diabetes.
Result: We found 366 (146 men and 220 women) new diabetes cases during follow-up. The risk-factor-adjusted
ORs for a 1 SD increase in TG, TC/HDL-C and TG/HDL-C were 1.23, 1.27 and 1.25 in men; the corresponding risks in
females were 1.36, 1.14, 1.39 respectively (all p < 0.05, except TC/HDL-C in females which was marginally
significant, p = 0.07). A 1 SD increase of HDL-C only in women decreased the risk of diabetes by 25% [0.75(0.64-
0.89)]. In both genders, there was no difference in the discriminatory power of different lipid measures to predict
incident diabetes in the risk factor adjusted models (ROC ≈ 82%). TG cutoff values of 1.98 and 1.66 mmol/l; TG/
HDL-C cutoff values of 4.7 and 3.7, in men and women, respectively, TC/HDL-C cutoff value of 5.3 in both genders
and HDL-C cutoff value of 1.18 mmol/l in women yielded the MAXss for defining the incidence of diabetes.
Conclusion: TC/HDL-C and TG/HDL-C showed similar performance for diabetes prediction in men population
however; among women TG/HDL-C highlighted higher risk than did TC/HDL-C, although there was no difference
in discriminatory power. Importantly, HDL-C had a protective effect for incident diabetes only among women.
Background
The prevalence and incidence of type 2 diabetes (here-
after diabetes) are high in the Middle Eastern countries
[1-3], which are estimated, will have the largest increases
in the prevalence of diabetes by 2030 [4].The prevalence
of Type 2 diabetes is reported to be over 14% in Tehran,
Iran, with an estimated incidence of new cases in about
1% per year [2,3]. This could be due to changes in life
style including “nutrition transition” and very low levels
of physical activity that, in recent years have been the
consequences of rapid urbanization and technological
transition, leading to a rapid rise in risk factors of
diabetes like dyslipoproteinemia [5,6].
The prevalence of dyslipoproteinemia among a Tehra-
nian adult population was reported to be high i.e. ≥55%
total cholesterol (TC) ≥5.18 mmol/l, 47% triglycerides
(TG) ≥1.69 mmol/l and 30% of men and 13% of women
with high density lipoprotein cholestrol (HDL-C) <0.9
mmol/l [7]. The association of high TG and/or low
HDL-C with incident diabetes is well known as Ameri-
can Diabetes Association (ADA) recommended “screen-
ing of adults for diabetes at any age with body mass
index (BMI) ≥25 kg/m
2, HDL-C level <0.90 mmol/l
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adults, high TG was shown to be an independent pre-
dictor of incident diabetes [3]. Despite this, to best of
our knowledge, no study has specifically assessed the
diabetes risk associated with lipid ratios (i.e. TC/HDL-C
and TG/HDL-C). Hence, the aim of this study was to
compare head -to head the independent association
between the different lipid indices with incident diabetes
during ≈6 years follow up in Iranian adult men and
women. Furthermore, we aimed to determine the appro-
priate cutoff values of these measures for incident dia-
betes in both genders.
Methods
Study population
Subjects in this study were selected from among partici-
pants of the Tehran Lipid and Glucose Study (TLGS), a
prospective study to determine the risk factors and out-
comes for non-communicable diseases [9,10]. To sum-
marize, 15005 people aged 3 years and over, residents of
district-13 of Tehran, underwent a baseline examination
in February 1999 to August 2001. After this cross-sec-
tional phase, subjects were categorized into the cohort
and intervention groups, the latter to be educated for
implementation of life style modifications. 10368 partici-
pants aged 20 years and more were selected to be
included into current study. After exclusion of subjects
with prevalent diabetes at baseline (n = 1164), those
with missing data regarding fasting and 2-hours plasma
glucose (n = 884) and those with missing data for any
of lipids, blood pressure measures, family history of dia-
betes, smoking behavior, BMI and waist circumference
(WC) (n = 275), there were 8045 non-diabetic subjects
which were re-assessed in the 2 consecutive phases at
approximately 3-year intervals; the second phase exami-
nations carried out between September 2001 and
August 2005, and the third phase between April 2005
and March 2008 (Figure 1). Finally, 5201 subjects who
developed diabetes (in phase 2 or 3) or completed the
phase 3 examinations were included in this study. The
ethical committee of the Research Institute for Endo-
crine Sciences approved this study and informed written
consent was obtained from all subjects.
Clinical and laboratory measurements
The baseline information including demographic data,
medications use, family history of diabetes, past medical
history of cardiovascular dieses (CVD) and smoking
behavior were collected by a trained interviewer, using a
pretested questionnaire. Weight was measured, while
subjects were minimally clothed without shoes, using
digital scales (Seca 707, Seca Corp., Hanover, MD; range
0.1-150 kg) and recorded to the nearest 100 g. Height
was measured in a standing position without shoes,
using tape meter with shoulders in normal alignment.
BMI was calculated as weight (kg) divided by square of
height (m
2). WC was measured at umbilical level, using
an unstretched tape meter, without any pressure to
body surface over light clothing. Two measurements of
systolic and diastolic blood pressure (SBP and DBP,
respectively) were taken using a standardized mercury
sphygmomanometer (calibrated by the Iranian Institute
of Standards and Industrial Researches) on the right
arm, after a 15 minute rest in a sitting position; mean of
the two measurements was considered as subject’s blood
pressure. A blood sample was drawn between 7:00 and
9:00 AM from all study participants after 12-14 h over-
night fasting. All the blood analyses were done at the
TLGS research laboratory on the day of blood collec-
tion. Plasma glucose was measured using an enzymatic
colorimetric method with glucose oxidase. The standard
oral glucose tolerance test (OGTT) was performed for
all participants not on glucose-lowering drugs. TC was
assayed using enzymatic colorimetric method with cho-
lesterol esterase and cholesterol oxidase. HDL-C was
measured after precipitation of the apolipoprotein
B-containing lipoproteins with phosphotungstic acid.
TG was assayed using an enzymatic colorimetric
method with glycerol phosphate oxidase. These analyses
were performed using commercial kits (Pars Azmoon
Inc., Tehran, Iran) and a Selectra 2 auto analyzer (Vital
Scientific, Spankeren, The Netherlands). Non-HDL-C
was calculated by subtracting HDL-C from TC; TC/
HDL-C and TG/HDL-C were calculated by dividing TC
and TG to HDL-C respectively. The intra- and inter-
assay coefficients of variation (CV) were both 2.2% for
glucose. For both total and HDL-Cholesterol, intra- and
inter-assay CVs were 0.5 and 2% respectively. Intra- and
inter-assay CVs were 0.6 and 1.6% for TG respectively
[9,10].
Definition of terms
Positive family history of diabetes was defined as having
at least one parent or sibling with diabetes. History of
CVD was defined any history of ischemic heart disease
and/or cerebrovascular accidents. Based on ADA defini-
tions of diabetes, those who used anti-diabetic drugs or
had fasting plasma glucose (FPG) ≥7 mmol/l or 2 hours
plasma glucose (2 hPG) ≥11.1 mmol/l were considered as
diabetic individuals and those with 2 hPG between 7.77
and 11.1 mmol/l were defined as impaired glucose toler-
ance (IGT) [11]. The other diabetes risk factors were
defined as follows: General obesity: BMI < 25 = normal
weight, 25-29.9 = overweight and ≥30 kg/m
2 = obese;
abdominal obesity: WC ≥90 cm in both genders, applying
Iranian cutoff, at risk for CVD risk factors requiring life
style changes [12]; hypertension: blood pressure ≥140/90
mmHg and/or taking of antihypertensive medication.
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regular or occasional smoking, “past” smokers were those
who used to smoke in the past, while those who had
never smoked were called “never” smokers.
Statistics
Mean (standard deviation: SD) values for continuous
and frequencies (%) for categorical variables of the base-
line characteristics including lipid measures are given
for participants with and without incident diabetes.
Since TG and TG/HDL-C had skewed distribution they
are shown as median (interquartile range). Comparison
of baseline characteristics between participants with and
without diabetes was done by student’s t-test for contin-
uous variables, chi-square test for categorical variables
and Mann-Whitney test for skewed variables. Logistic
regression analysis was used to study the associations of
lipid measures with incident diabetes. Cox proportional
hazards models for interval censored data, were used as
alternate analyses (with Epi package in R program); the
results were essentially identical with logistic models
and only logistic regression results are presented.
Figure 1 Follow up status of the TLGS participants after the baseline examination.
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logistic regression models, univariate analysis was used
for each candidate covariate (age, history of CVD, family
history of diabetes, intervention group, hypertension,
abdominal obesity, general obesity, smoking status, IGT
and lipid lowering drugs use); following this, each covari-
ate that had a P value less than 0.2 in the univariate ana-
lysis, was selected to be included in a stepwise backward
(P remove:0.1) multivariate logistic regression analysis. In
men, final covariates were hypertension, general obesity,
IGT and family history of diabetes; in women these were
age, abdominal obesity, general obesity, IGT and family
history of diabetes. Each final model included these cov-
ariates plus one of the lipid measures (TG and TG/HDL-
C were added as log-transformed value). Age and multi-
variate odds ratios (ORs), with 95% confidence intervals
(CI), were calculated for every 1 SD increase in the value
of each lipid parameters. Model fitness was assessed with
Hosmer-Lemeshow test; statistically significant X
2 statis-
tics from this test indicate poor model fitness. The pre-
dictive ability of each model was examined with area
under the receiver operating characteristic (aROC) curves
and compared with “roccomp” STATA command.
To determinate appropriate cutoff values of each lipid
measure for predicting diabetes, the ROC curve analysis
was used with an estimation of the variable’s sensitivity
and specificity. In both genders, the cutoff point of each
lipid variable, was assessed by the minimum value of √
(1-sensitivity)
2 + (1-specificity)
2 [13] which representes
the maximum sums of sensitivity and specificity
(MAXss).
SPSS program (SPSS Inc., Chicago, IL, USA; Version 15)
and STATA software (Version 10) were used for data ana-
lysis and P-values <0.05 were considered statistically
significant.
Results
The study population included 2173 men and 3028
w o m e nw i t hm e a na g eo f4 3 . 3a n d4 0 . 8y e a r s ,r e s p e c -
tively. After a median follow-up of 6.4 years, 366 (146
men and 220 women) new cases of diabetes were
identified.
Subjects followed, compared with those non-followed
had higher rate of baseline positive family history of dia-
betes, general and abdominal obesity and lower rate of
smoking behavior and participation in the intervention
group. No significant difference was found between the
two groups in baseline hypertension and IGT (data not
shown).
The baseline characteristics of men and women based
on incident diabetes are shown in Table 1.
The men who developed diabetes were older com-
pared to those without diabetes and had higher preva-
lence of family history of diabetes, hypertension, general
and abdominal obesity and IGT. All baseline lipid mea-
sures levels, except for HDL-C, were higher in men with
incident diabetes compared to those without it. Women
with incident diabetes were older than those without
this condition. Rates of positive family history of dia-
betes, history of CVD, hypertension, general and abdom-
inal obesity, lipid-lowering drug use and IGT were
higher in women who developed diabetes compared
those did not. All lipids values were higher in women
with incident than in women without incident diabetes,
except HDL-C level which was higher in subjects with-
out incident diabetes.
The ORs of a 1 SD change in each lipid marker or
index, in men and women, are presented in Table 2. In
men, in the age adjusted model, there was positive asso-
ciation between TC, TG, non-HDL-C, TC/HDL-C and
TG/HDL-C with incident diabetes; but in the fullly
adjusted model, only, TG, TC/HDL-C and TG/HDL-C
were independent predictors of diabetes and a 1 SD
increase in each of these lipids increased risk of diabetes
by 23%, 27% and 25%, respectively. In women, a 1 SD
change of all lipid measures, except for TC, resulted in
a significant risk of incident diabetes in age adjusted
model. However, after further adjustment, HDL-C, TG
and TG/HDL-C remained as independent predictors of
diabetes; a 0.3 mmol/L increase in HDL-C decrease the
risk of diabetes by 25% and a 1 SD increase in log-trans-
formed TG and TG/HDL-C, resulted 36% and 39%
increased risk of incident diabetes in multivariate
adjusted model in women. Additionally, in this group, a
1.7 increase in TC/HDL-C increased the risk of diabetes
≈14% in full adjusted analysis which was marginally sig-
nificant (P = 0.07).
The Hosmer-Lemeshow test did not reject the good-
ness of fit for the models (all P > 0.4). Predictive ability
(as assessed by aROC) of these models were statistically
equal (all P value > 0.05) in each gender.
Table 3 presents the cutoff points of lipid measures
for prediction of diabetes with their corresponding spe-
cificity and sensitivity in men and women. Cutoff points
of TG, TC/HDL-C and TG/HDL-C to predict diabetes
in men and women were 1.98 and 1.66 mmol/l, 5.3 and
5.3, 4.7 and 3.7, respectively. Also the corresponding
cutoff value of HDL-C in women was 1.18 mmol/l.
We also used a method for defining the cutoff points
of lipid measures to facilitate the identification of 70%
of future cases of diabetes (that is, a sensitivity of ≈70%)
(Table 4). The results, as expected, produced lower cut-
o f fp o i n t so fT G ,T G / H D L - Ca n dT C / H D L - Ca n d
higher cut point of HDL-C in predicting diabetes.
Discussion
In a population with high prevalence and incidence of
diabetes, our findings highlighted TG, TG/HDL-C and
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Men Women
Incident diabetes
(146)
No diabetes
(2027)
P Value Incident diabetes
(220)
No diabetes
(2808)
P Value
Age (year) 49.1 ± 13.5 42.8 ± 14.0 <0.001 46.6 ± 11.7 40.3 ± 12.5 <0.001
Family history of diabetes (%) 39.7 24.0 <0.001 42.3 26.4 <0.001
Intervention (%) 39.7 35.4 0.3 35.0 36.2 0.7
History of CVD (%) 6.8 3.9 0.09 5.9 2.3 0.001
Smoking (%) 0.9 0.5
Never 62.3 60.5 94.5 96.2
Past 13.7 13.7 1.8 1.2
Current 25.0 25.8 3.6 2.5
Hypertension (%) 37.7 17.5 <0.001 36.8 18.0 <0.001
Obesity (%) <0.001 <0.001
Normal weight 21.2 43.7 11.4 31.7
Overweight 47.3 43.4 34.5 40.9
Obese 31.5 13.0 54.1 27.4
Abdominal obesity (%) 67.8 45.1 <0.001 72.3 41.0 <0.001
Lipid-lowering drug use (%) 1.5 2.1 0.6 6.4 2.6 0.001
Impaired glucose tolerance (%) 54.1 9.5 <0.001 55.9 11.4 <0.001
Triglycerides (mmol/l) 2.1 (1.5-3.0) 1.7(1.8-2.4) <0.001 2.1 (1.4-3.0) 1.4(1.0-2.1) <0.001
Total cholesterol (mmol/l) 5.6 ± 1.2 5.3 ± 1.1 <0.001 5.6 ± 1.3 5.4 ± 1.2 <0.001
HDL-C (mmol/l) 0.9 ± 0.3 1.0 ± 0.2 0.2 1.1 ± 0.2 1.7 ± 0.3 <0.001
Non-HDL-C (mmol/l) 4.7 ± 1.2 4.3 ± 1.1 <0.001 4.8 ± 1.3 4.2 ± 1.2 <0.001
TC/HDL-C 6.2 ± 2.2 5.6 ± 1.6 <0.001 5.7 ± 1.8 4.9 ± 1.6 <0.001
TG/HDL-C 5.1(3.4-8.2) 4.0(2.5-6.3) <0.001 4.5(2.8-7.0) 2.7 (1.8 -4.5) <0.001
CVD: Cardiovascular disease, HDL-C: High density lipoprotein cholesterol, Mean ± SD are shown for continuous variables and P value is calculated with t-test; % is
shown for categorical variables with P value according to chi-square; TG and TG/HDL are shown as median (interquartile range) and P value according to Mann-
Whitney test. For categorical variables with more than 2 values, the first category was considered as the reference and the p-value is for linear trend in risk.
Obesity: BMI < 25 (normal), 25-29.9 (overweight) and ≥30 kg/m2 (obese), Abdominal obesity: waist circumference ≥90 cm in both sexes; Hypertension: Blood
pressure ≥140/90 mmHg and/or taking of antihypertensive medication; IGT: 2-hours plasma glucose level between 7.77-11.1 mmol/l.
Table 2 Odds ratios of lipid measures for incident diabetes mellitus
Age adjusted model multivariate adjusted model
SD mmol/l Odds ratio
(95%CI)
P value Odds ratio
(95%CI)
P value H-L X
2 (P value) aROC
(95%CI)
men
TC 1.1 1.28(1.09-1.52) 0.002 1.11(0.93-1.33) 0.2 5.65(0.7) 0.81
HDL-C 0.2 0.86(0.72-1.02) 0.1 0.91(0.75-1.09) 0.3 5.05(0.7) 0.81
TG 0.6* 1.62(1.37-1.92) <0.001 1.23(1.02-1.49) 0.03 5.53(0.7) 0.82
Non-HDL-C 1.1 1.34(1.13-1.58) <0.001 1.14(0.95-1.37) 0.15 6.59(0.6) 0.81
TC/HDL-C 1.7 1.44(1.22-1.69) <0.001 1.27(1.06-1.51) 0.007 2.97(0.9) 0.82
TG/HDL-C 0.7* 1.44(1.25-1.65) <0.001 1.25(1.03-1.52) 0.02 6.11(0.6) 0.82
women
TC 1.2 1.15(0.98-1.32) 0.1 0.94(0.80-1.12) 0.52 5.52 (0.7) 0.81
HDL-C 0.3 0.66(0.56-0.76) <0.001 0.75(0.64-0.89) 0.001 3.67(0.9) 0.82
TG 0.5* 1.74(1.50-2.01) <0.001 1.36(1.13-1.58) 0.001 7.94(0.4) 0.82
Non-HDL-C 1.2 1.26(1.09-1.45) 0.003 1.01(0.86-1.19) 0.86 4.34(0.8) 0.81
TC/HDL-C 1.7 1.37(1.21-1.55) <0.001 1.14(0.99-1.31) 0.07 5.66(0.7) 0.81
TG/HDL-C 0.7* 1.78(1.53-2.06) <0.001 1.39(1.17-1.64) <0.001 7.47(0.5) 0.82
TC: total cholesterol, HDL-C: high density lipoprotein cholesterol, TG: triglycerides, SD: standard deviation, CI: confidence interval. aROC: area under the receiver
operating characteristic of each model. Odd ratios indicate the increase risk for a 1 SD increase of each lipid parameter Multivariate models were adjusted for
hypertension, family history of diabetes, general obesity and impaired glucose tolerance in men and for age, family history of diabetes, general obesity,
abdominal obesity and impaired glucose tolerance in women. H-L X
2 indicates Hosmer and Lemeshow goodness of fit test. * SD of log-transformed.
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betes, among men, during ≈6 years follow up with the
ORs for a 1 SD increase in these lipid measures ranging
from 23 to 27%. Furthermore, among women, TG, TC/
HDL-C and TG/HDL-C were independent predictors
with the ORs ranging from 14% for TC/HDL-C (mar-
ginally significant) to ≈40% for TG/HDL-C. HDL-C only
among women was an independent protective lipid mea-
sure for incident diabetes. Our study showed that in this
study population, the TG cutoff values of 1.98 and 1.66
mmol/l; TG/HDL-C cutoff values of 4.7 and 3.7, in men
and women, respectively, TC/HDL-C cutoff value of 5.3
in both genders and HDL-C cutoff value of 1.18 mmol/l
in women yielded the MAXss for defining the incidence
of diabetes.
In the current study, serum TG was a strong predictor
of incident diabetes in both genders; independent of the
other risk factors. The association of fasting TG with
incident diabetes has been documented previously
[14,15]. However, this was reported largely when TG
levels were pooled with additional risk factors for dia-
betes or cardiovascular disease [16]. However, Tirosh et
al highlighted that two measurements of fasting trigly-
ceride levels with 5 years interval can predict incident
diabetes in healthy young men independent of tradi-
tional risk factors [16]. Furthermore, the cut off points
of TG in men (≈1.92 mmol/l) and women (≈1.69 mmol/
l) to predict incident diabetes in this study of an Iranian
population were clearly lower than those recommended
by ADA for screening diabetes [8], nevertheless, these
values were closer to the TG criteria of metabolic syn-
drome (i.e. 1.69 mmol/l) [17].
L o wH D L - Ci sk n o w nt ob ea ni m p o r t a n tp r e d i c t o r
for development of diabetes [18], and certain agents
known to raise HDL-C improve glucose metabolism and
prevent diabetes [19]. In the current study, serum HDL-
C was a strong independent negative risk factor of dia-
betes in women. An increment of 0.3 mmol/l in HDL-C
was associated with a 25 percent lower risk of incident
diabetes among women but did not predict diabetes in
men even in age adjusted analysis. Similarly, in Finn-
mark Study, a significant predictive relevance of HDL-C
was shown only in women [20]. In contrast to our
results, some studies showed that HDL-C had a signifi-
cant relationship with incident diabetes in men but not
in women [21,22]; Also there were some evidences
demonstrating HDL-C was inversely associated with dia-
betes in both genders [23].
Despite the controversy, accumulating evidence indi-
cates that both low HDL-C and hypertriglyceridemia
which previously were known as early manifestations of
insulin resistance (IR) and later diabetes, can actively
add to b cell failure and thus to the appearance of dia-
betes [24].
Although several studies demonstrated that lipid
ratios, such as TC/HDL, could be better predictors of
CVD than any single lipid measures [25], there is lack of
data regarding lipid ratios for predicting diabetes. Kimm
et al showed that lipid ratios including TC/HDL and
TG/HDL were associated with IR and might be used as
integrated lipid values [26]. Jespersen et al in a cross
sectional study among normal and overweight non-dia-
betic individuals showed that those with high value of
TC/HDL-C were more resistant to insulin-stimulated
glucose disposal, and to had higher blood pressure,
increased TG concentrations, and hyperinsulinemia [27],
rendering these individuals at increased risk of coronary
heart disease and possibly diabetes for reasons unrelated
to cholesterol metabolism. Among obese individuals,
however, Brehm et al showed that these relationships do
not exist [28]. In the current study, the multivariate OR
Table 3 Receiver operator curve characteristics for significant lipid measures in predicting diabetes and cutoff points
for maximum sum of sensitivity and specificity in men and women
Men Women
aROC
(95% CI)
Cut
point
Sensitivity
(%)
Specificity
(%)
aROC
(95% CI)
Cut
point
Sensitivity
(%)
Specificity
(%)
TG 0.62(0.57-0.66) 1.98 0.57 0.61 0.67 (0.65-0.72) 1.66 0.67 0.60
HDL-C 0.60 (0.57-0.64) 1.18 0.49 0.36
TC/HDL-C 0.59(0.53-0.63) 5.3 0.65 0.48 0.65 (0.61-0.68) 5.3 0.57 0.66
TG/HDL-C 0.60(0.56-0.65) 4.7 0.57 0.59 0.69 (0.65-0.72) 3.7 0.66 0.64
aROC: area under the receiver operating characteristic; TC: total cholesterol, HDL-C: high density lipoprotein cholesterol, TG: triglycerides. Cut points are
presented as mmol/l
Table 4 Receiver operator curve characteristics for
significant lipid measures in predicting diabetes and
cutoff points for sensitivity ≈70% in men and women
Men Women
Cut point Specificity (%) Cut point Specificity (%)
TG 1.61 45 1.54 55
HDL-C 1.19 50
TC/HDL-C 5.1 43 4.77 53
TG/HDL-C 3.66 44 3.4 59
TC: total cholesterol, HDL-C: high density lipoprotein cholesterol, TG:
triglycerides. Cut points are presented as mmol/l
Hadaegh et al. Lipids in Health and Disease 2010, 9:85
http://www.lipidworld.com/content/9/1/85
Page 6 of 9associated with a 1 SD increase in TC/HDL-C was
approximately 1.27 and 1.14 in men and women, respec-
tively; yielding a similar cutoff point of 5.3 to predict
incident diabetes.
It was shown in the previous studies that TG/HDL-C
is as close as fasting plasma insulin concentration with
IR and could be used as an indicator of IR in clinical
setting [29,30]; as TG/HDL > 3.5 is a strong indicator of
t h ep r e s e n c eo fI R .T h i sr a t i oc o r r e l a t e dw e l lw i t ht h e
insulin suppression test and was effective as the ATP III
MS criteria in identifying IR individuals [29,30]. Recently
we showed that prevalence of metabolic syndrome in
Iranian men with TG/HDL-C level of 2.8-4.4 is five-fold
higher than those with TG/HDL-C < 2.8 [31]. Further-
more, TG/HDL-C ≥ 3.5 was an independent predictor
of incident diabetes and along with SBP, family history
of diabetes, waist-to-height ratio and fasting plasma glu-
cose levels ≥5m m o l / ls h o w e da R O Co f0 . 8 3( 9 5 %C I
0.80-0.86) to discriminate subjects at substantial risk for
diabetes among Iranian population [32]. In our data
analyses, a 1 SD increase in TG/HDL-C yielded higher
risk for incident diabetes in women than in men (39%
vs. 25%) and also a lower cutoff point in women showed
more sensitivity and specificity than in men. McLaughlin
et al, however, did not identify any interaction between
sex and the ability of the TG/HDL-C ratio to predict IR
in 127 men and 131 women [29]. Generally, considering
effect sizes (ORs with CI) and model discrimination (as
assessed by aROC), TC/HDL-C and TG/HDL-C showed
similar performance for diabetes prediction in men,
however; among women TG/HDL-C highlighted higher
risk than did TC/HDL-C, although there was no differ-
ence in discriminatory power. On the other hand, TC/
HDL-C besides being as inexpensive and simple to mea-
sure as the TG/HDL-C has the additional benefit of its
biologic inconsistency being much lower and fasting
state is not needed [33].
In our data analysis, we used ROC analysis to calcu-
late the cutoff points of lipid variables based on equally
weighted sensitivity and specificity [13], hence these cut-
off points had low sensitivity for predicting diabetes in
clinical practice. Additionally, these points may not be
the optimal cutoff in the clinic because sensitivity versus
specificity should be weighted against many other fac-
tors such as seriousness of the illness, how invasive or
feasible it might be, the test used for first evaluation and
finally how often the test should be performed [34].
Furthermore, to cover a reasonable proportion of the
population at risk, we calculated the cutoff point of each
lipid measure with sensitivity at the level of at least 70%
(not to miss more than 30% cases of incident diabetes)
and as expected, produced lower cutoff points of lipid
parameters with lower specificities.
There are potential limitations regarding the interpre-
tation of our results. First, we measured TC, HDL-C
and TG only once at the baseline per subject, thus the
potential bias resulting from regression dilution of TG
a n dH D L - Cc o u l dn o tb ei g n o r e d[ 3 5 ] ,a d d i t i o n a l l y ,
given the significant intraindividual variation in fasting
TG level, it might be possible that a proportion of parti-
cipants who had a high concentration of TG are falsely
classified as low, and vice versa; hence, attenuating the
true relative risk of the lipoprotein. Second some mis-
classification of diabetes status may have occurred due
to defining new diagnosed diabetes with a single OGTT
at baseline or follow up. However, the extent of misclas-
sification would have to be extensive to change the
r e s u l t so ft h i ss t u d y[ 3 6 ] .T h i r d ,w ed i dn o te v a l u a t e
low-density lipoprotein cholesterol because it was calcu-
lated, rather than measured, in TLGS (i.e. requiring
exclusion of participants with TG ≥ 4.52 mmol/l),
although it has not been reported to have a strong cor-
relation with IR in the literature [37]. Furthermore, we
did not evaluate apolipoproteins because they have not
been as routinely used as TC, TG and HDL-C as predic-
tors of IR and incident diabetes.
As strength, to our best knowledge, this study was the
first prospective and population-based study, which
examined different lipid measures simultaneously for
prediction of diabetes in both genders.
Conclusions
TC/HDL-C and TG/HDL-C showed similar perfor-
mance for diabetes prediction in men population; how-
ever, among women TG/HDL-C highlighted higher risk
than did TC/HDL-C, although there was no difference
in discriminatory power. Importantly, HDL-C had a pro-
tective effect for incident diabetes only among women.
Hence, although we cannot infer causality from our
observational study, it is worth speculating that lowering
TG/HDL-C and TC/HDL-C levels in both genders
either pharmacologically or through lifestyle modifica-
tion, may constitute a viable means to attenuate diabetes
risk in Iranian population.
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